scispace - formally typeset
C

Catherine McDermott

Researcher at Bond University

Publications -  63
Citations -  5581

Catherine McDermott is an academic researcher from Bond University. The author has contributed to research in topics: Pyocyanin & Acetylcholine. The author has an hindex of 15, co-authored 60 publications receiving 4441 citations. Previous affiliations of Catherine McDermott include University College Cork.

Papers
More filters
Journal ArticleDOI

Protection against Radiotherapy-Induced Toxicity.

TL;DR: The aim of this review was to evaluate and summarise the evidence that exists for both the known radioprotectant agents and the agents that show promise as future radioprotsection agents.
Journal ArticleDOI

Pyocyanin-induced toxicity in A549 respiratory cells is causally linked to oxidative stress.

TL;DR: Parallel measures of ROS production, antioxidant levels and cytotoxicity provide convincing evidence that pyocyanin-induced cytot toxicity in A549 respiratory cells is mediated by acute ROS production and subsequent oxidative stress.
Journal ArticleDOI

Effects of pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viability

TL;DR: The virulence factor depressed stimulated adenosine triphosphate release, which to the authors' knowledge is a novel finding with implications for awareness of bladder filling in patients with P. aeruginosa urinary tract infection.
Journal ArticleDOI

Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.

TL;DR: CAA in addition to acrolein contributes to the urotoxicity of cyclophosphamide and ifosfamide, and Alterations in urothelial cell viability and mediator release may be causally linked to oxidative stress, with NAC providing protection against changes.
Journal ArticleDOI

Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E2 release by doxorubicin

TL;DR: Findings indicate that inflammatory cytokines interleukin-8 and -1β are induced and urothelial mediator release is affected by treatment with doxorubicin at clinically relevant concentrations and durations of treatment.